Fumikata Hara
- Cancer Research top 10%
- Breast Cancer Treatment Studies 31
- Cancer Genomics and Diagnostics 5
- Oncology top 5%
- HER2/EGFR in Cancer Research 34
- Cancer Treatment and Pharmacology 32
- Peptidase Inhibition and Analysis 5
-
- Advanced Breast Cancer Therapies 18
- Lung Cancer Treatments and Mutations 7
-
- Multiple Myeloma Research and Treatments 5
Fumikata Hara
80 papers receiving 871 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 298
- Oncology 501
- Pulmonary and Respiratory Medicine 277
- Radiology, Nuclear Medicine and Imaging 130
- Pathology and Forensic Medicine 90
Countries citing papers authored by Fumikata Hara
This map shows the geographic impact of Fumikata Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumikata Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumikata Hara more than expected).
Fields of papers citing papers by Fumikata Hara
This network shows the impact of papers produced by Fumikata Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumikata Hara. The network helps show where Fumikata Hara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fumikata Hara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 8 | |
| 11 | 2018 | 3 | |
| 12 | 2018 | 41 | |
| 13 | 2016 | 68 | |
| 14 | 2015 | 9 | |
| 15 | 2014 | 21 | |
| 16 | 2014 | 12 | |
| 17 | 2011 | 1 | |
| 18 | 2010 | 15 | |
| 19 | 2008 | 9 | |
| 20 | 2006 | 22 |
About Fumikata Hara
Fumikata Hara is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 883 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (34 papers), Cancer Treatment and Pharmacology (32 papers), Breast Cancer Treatment Studies (31 papers), Advanced Breast Cancer Therapies (18 papers), Lung Cancer Treatments and Mutations (7 papers), Multiple Myeloma Research and Treatments (5 papers), Peptidase Inhibition and Analysis (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Cancer Research (298 citations), Oncology (501 citations) and Pulmonary and Respiratory Medicine (277 citations). Fumikata Hara has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Naruto Taira, Shozo Ohsumi, Daisuke Takabatake, Hirofumi Mukai, Tadahiko Shien, Hiroyoshi Doihara, Kenjiro Aogi, Seiki Takashima, Nobuyoshi Shimizu and Tatsuya Toyama. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.